Telegram-Icon YouTube-Icon whatsapp-Icon
Search Stock:

Glenmark Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages

Glenmark Pharmaceuticals Share Price

Symbol: GLENMARK
Share Price: ₹2,460.00
▼ 10.40 (0.42%)
Open ₹2,455.00
Day High ₹2,476.90
Day Low ₹2,420.00
Prev. Close ₹2,470.40
Volume 516,029

Price on NSE

Glenmark Pharmaceuticals Share Price

Symbol: GLENMARK (BSE Code: 532296)
Share Price: ₹2,451.70
▼ 12.50 (0.51%)
Open ₹2,464.10
Day High ₹2,474.00
Day Low ₹2,422.10
Prev. Close ₹2,464.20
Volume 13,919

Price on BSE

Glenmark Pharmaceuticals (GLENMARK (BSE Code: 532296)) Key Ratios

P/E
Company35.67
Sector11.03
A Price-to-Earnings of 35.67 means investors pay 35.67 units per 1 unit of earnings. This is higher than the sector average of 11.03.
P/B
Company6.1
Sector4.32
A P/B ratio of 6.1 shows market value relative to book value. This is higher than the sector average of 4.32.
ROA
Company9.03%
Sector2.32%
Return on Assets shows a 9.03% profit per unit of asset. This is higher than the sector average of 2.32%.
ROE
Company28.08%
Sector-3.38%
Return on Equity creates 28.08% profit per unit of equity. This is higher than the sector average of -3.38%.
ROCE
Company32.7%
Sector5.67%
ROCE indicates 32.7% operating earnings per unit of capital. This is higher than the sector average of 5.67%.
EV/EBITDA
Company18.98
Sector23.48
EV/EBITDA of 18.98 means value is 18.98 times core earnings. This is lower than the sector average of 23.48.

Glenmark Pharmaceuticals Share Price Analysis Local DB

Glenmark Pharmaceuticals share price is ₹2,460.00, day high (share price) is ₹2,476.90, day low (share price) is ₹2,420.00 and volume is 516,029. 52 Week high share price for Glenmark Pharmaceuticals is ₹2,537.60 on 28 Aug 2026 and 52 week low share price for Glenmark Pharmaceuticals is ₹1,792.60 on 28 Oct 2025. Price data as of: 02 Sep, 2026 3:31 PM.

According to latest price data (as of 02 Sep, 2026 3:31 PM) for Glenmark Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 64.4, 50 DMA (50 Displaced Moving Average) is 2,280.80 and 200 DMA (200 Displaced Moving Average) is 2,149.73.

▼ ₹2,460.00
-10.40 (-0.42%)
As of 02 Sep, 2026
Open ₹2,455.00
Day High - Low ₹2,476.90 - ₹2,420.00
Volume 516,029
52 Weeks High ₹2,537.60 on 28 Aug 2026
52 Weeks Low ₹1,792.60 on 28 Oct 2025
RSI (14) 64.4
50 DMA 2,280.80
200 DMA 2,149.73
Loading...

Glenmark Pharmaceuticals (GLENMARK) Technical Analysis

₹2,460.00 -10.40
02 Sep, 2026

Glenmark Pharmaceuticals Technical Data and Analysis available in multiple timeframes.

Glenmark Pharmaceuticals Oscillators Analysis

On the Day timeframe, the outlook for GLENMARK is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 64.4.

Glenmark Pharmaceuticals Price Action

Glenmark Pharmaceuticals Oscillators Overview

IndicatorValue
RSI (14)64.37
Stoch %K (14, 3, 3)78.59
CCI (20)90.52
ADX (14)23.00
Awesome Osc173.46
Momentum (10)213.50
MACD (12, 26, 9)60.32
MACD Signal47.24
Stoch RSI (14)71.17
Williams %R (14)-24.63
Bull/Bear Power75.57
Ultimate Osc59.59
MFI (14)55.45
ROC (21)10.56
ROC (125)15.13
ATR (14)60.18

Glenmark Pharmaceuticals Moving Averages

GLENMARK is trading above 13 out of 14 SMAs.
2,460.00
CURRENT PRICE
Bullish Moving Averages
13
Bearish Moving Averages
1
5 SMA2,477.08
8 SMA2,451.80
9 SMA2,436.92
10 SMA2,426.52
12 SMA2,401.39
20 SMA2,357.53
21 SMA2,352.83
26 SMA2,328.86
30 SMA2,310.94
34 SMA2,301.33
50 SMA2,280.80
100 SMA2,275.86
150 SMA2,209.84
200 SMA2,149.73
Ichimoku Base2,349.80Above Base
VWMA (20)2,372.21Above VWMA
HMA (9)2,500.18Below HMA

Glenmark Pharmaceuticals Technical SWOT Analysis

STRENGTHS
  • Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
  • Price is above the 50 DMA, suggesting supportive medium-term trend structure.
  • MACD is above the signal line and in positive territory, reflecting supportive momentum.
  • RSI at 64.37 indicates relatively strong momentum without being overbought.
WEAKNESSES
  • No notable technical weakness signals are currently observed.
OPPORTUNITIES
  • No specific opportunity signals are identified; the setup appears neutral.
THREATS
  • No immediate technical risk signals are identified.

Glenmark Pharmaceuticals Daily Pivot Points (Support & Resistance)

Level Classic Woodie's Camarilla Fibonacci
Resistance 32,531.772,514.852,481.372,513.33
Resistance 22,513.332,504.882,477.722,498.09
Resistance 12,491.872,474.952,474.062,488.68
Pivot Point2,473.432,464.982,470.402,473.43
Support 12,451.972,435.052,466.742,458.19
Support 22,433.532,425.082,463.092,448.78
Support 32,412.072,395.152,459.432,433.53
Daily Historical Technical Data of Glenmark Pharmaceuticals
Records:
Date Close ADX PDI MDI Aroon Up Aroon Down Bollinger UB Bollinger MB Bollinger LB CCI CMF MACD Signal MFI PSAR RSI (F) RSI Sto (F) %K %D Supertrend Ult Osc Wil %R
Synchronizing oscillators history...
Daily Historical Moving Averages of Glenmark Pharmaceuticals
Records:
Date Close SMA(5)EMA(5)SMA(8)EMA(8)SMA(9)EMA(9)SMA(10)EMA(10)SMA(12)EMA(12)SMA(20)EMA(20)SMA(21)EMA(21)SMA(26)EMA(26)SMA(30)EMA(30)SMA(34)EMA(34)SMA(50)EMA(50)SMA(100)EMA(100)SMA(150)EMA(150)SMA(200)EMA(200) Ichimoku Base VWMA(20) HMA(9)
Synchronizing moving averages history...

Glenmark Pharmaceuticals Share Price Performance (NSE)

Period LTP Chg % Absolute Chg Prev LTP Result
1 Week
₹2,460.00
2 Sep 2026, Wed
 +0.00% +₹0.00
₹2,460.00
27 Aug 2026, Thu
 Bullish
1 Month
₹2,460.00
2 Sep 2026, Wed
 +10.31% +₹230.00
₹2,230.00
3 Aug 2026, Mon
 Bullish
3 Months
₹2,460.00
2 Sep 2026, Wed
 +13.16% +₹286.00
₹2,174.00
3 Jun 2026, Wed
 Bullish
6 Months
₹2,460.00
2 Sep 2026, Wed
 +15.86% +₹336.70
₹2,123.30
2 Mar 2026, Mon
 Bullish
9 Months
₹2,460.00
2 Sep 2026, Wed
 +25.13% +₹494.10
₹1,965.90
3 Dec 2025, Wed
 Bullish
1 Year
₹2,460.00
2 Sep 2026, Wed
 +22.73% +₹455.60
₹2,004.40
3 Sep 2025, Wed
 Bullish
2 Years
₹2,460.00
2 Sep 2026, Wed
 +45.78% +₹772.50
₹1,687.50
3 Sep 2024, Tue
 Bullish
3 Years
₹2,460.00
2 Sep 2026, Wed
 +224.95% +₹1,702.95
₹757.05
1 Sep 2023, Fri
 Bullish
4 Years
₹2,460.00
2 Sep 2026, Wed
 +565.49% +₹2,090.35
₹369.65
2 Sep 2022, Fri
 Bullish
5 Years
₹2,460.00
2 Sep 2026, Wed
 +360.89% +₹1,926.25
₹533.75
3 Sep 2021, Fri
 Bullish

Glenmark Pharmaceuticals - Shareholding Pattern

Historical breakdown of ownership percentages over time.

Category Jun 2026 Mar 2026 Dec 2025 Sep 2025
Promoters 46.65% 46.65% 46.65% 46.65%
FII 20.89% 20.34% 19.20% 20.73%
DII (Other) 1.85% 2.49% 2.23% 2.30%
Retail & Others 13.85% 13.72% 14.06% 14.01%
Mutual Funds 16.76% 16.80% 17.86% 16.31%

Glenmark Pharmaceuticals - Yearly Income Statement (in ₹ Crore)

Period Revenue Operating Profit Net Profit
Mar 2026 17,443.13 +29.83% 1,984.75 +41.85% 1,361.95 +30.06%
Mar 2025 13,435.46 +6.18% 1,399.21 +3733.45% 1,047.14 +173.05%
Mar 2024 12,653.09 +6.58% 36.50 -84.78% -1,433.52 -479.84%
Mar 2023 11,872.14 239.84 377.40

Glenmark Pharmaceuticals - Corporate Actions

Type Ex-Date Amount / Ratio Details
Dividend 03 Oct 2025 ₹2.5 View Details ▼
Announcement date 22 Sep 2025
Ex dividend date 03 Oct 2025
Record date 03 Oct 2025
Dividend type Interim
Amount 2.5
Dividend % 250.0
Details Rs.2.5000 per share(250%)Interim Dividend
Dividend 15 Sep 2025 ₹2.5 View Details ▼
Announcement date 23 May 2025
Ex dividend date 15 Sep 2025
Record date 15 Sep 2025
Dividend type Final
Amount 2.5
Dividend % 250.0
Details Rs.2.5000 per share(250%)Final Dividend

Glenmark Pharmaceuticals Share Price and Volume Historical Data

Synchronizing MarketBandhu Database...